At Roche, we are dedicated to innovating healthcare. By innovation, we mean the creation and commercialization of medically differentiated products that lead to a tangible improvement in the health, quality and length of life of our patients.

Our efforts are directed towards developing novel solutions for major unmet medical needs. At Roche, research and development are focused on five Disease Biology Areas (DBAs) – Central Nervous System, Inflammation, Metabolism, Oncology and Virology – and work on two of the five, Inflammation and Virology, is done at Palo Alto.